OBJECTIVE:
Participants should be able to discuss the unusual clinical, pathologic, and radiologic features of an antrochoanal polyp that can mimic a juvenile nasopharyngeal angiofibroma; and how the management of these two entities differs. METHOD: Case report and literature review RESULTS: Epistaxis is indeed a rare presentation of an antrochoanal polyp with few such documented cases in the literature. We present a case of a 23-year-old male with severe epistaxis and radiologic findings consistent with a juvenile nasopharyngeal angiofibroma. Final pathology, however, revealed a polyp. The clinical, pathologic, and radiologic findings in this case will be discussed as well as comparisons between potential confounding similarities in the presentation of these two distinct entities, ultimately requiring different management. CONCLUSION: Epistaxis is a common presentation of a juvenile nasopharyngeal angiofibroma. However, this clinical feature does not rule out the diagnosis of less likely etiologies of epistaxis such as an antrochoanal polyps which must be considered in the differential diagnosis to avoid potential errors in management.
Back and Forth Endoscopic Septoplasty: Technique and Results
Chiara Bellini, MD (presenter); Matteo Trimarchi, MD; Salvatore Toma, MD; Mario Bussi, MD OBJECTIVE: Describe our clinical experience in 243 consecutive patients undergoing endoscopic back-and-forth septoplasty (EBFS), discussing surgical indications, technique and follow-up. METHOD: From January 2005 to November 2008, 243 patients, 50 females and 193 males (age range 17.5-78.7 yr) underwent EBFS at the Department of Otorhinolaryngology, San Raffaele Hospital Milan. The indication of EBFS in our series was nasal airway obstruction (NAO). Patients were studied with nasal rigid endoscopy, and in some cases CT was used to exclude rhinosinusitis. The most common concomitant diagnoses included allergic rhinitis and turbinate hypertrophy. EBFS facilitates the interruption of perichondrial and periosteal bridges which are more represented in the anterior portion of the septum between the caudal quadrangular cartilage and the vomeropremaxillary crest. Septal splints were positioned. No nasal packing was required. RESULTS: No cases required conversion to a traditional headlight approach, and no intraoperative complications were encountered. 72% of intraoperative mucosal microlacerations occurred; suturing was required in only 8% cases. Of the 243 patients, 74.1% experienced resolution of nasal airway obstruction, while 16.4% experienced only improvement. 9.5% noted the persistence of symptoms. Complications included transient dental pain/hypesthesia (6.1%), septal hematoma (4.86%), septal perforation (1.64%), synechiae formation (2.05%), epistaxis (2.05%), cheek swelling (0.41%), septal abscess (0.41%). CONCLUSION: EBFS is a viable alternative to traditional headlight septoplasty with very good outcomes and acceptable complications. This technique allows to lise the tissue fibers preserving the integrity of mucosa at the critical area using less force, reducing the probability of mucosal tears.
Berberine Suppresses MUC5AC Gene in Airway Epithelial Cells
Young Hoon Kim, MD (presenter); Na-Hyun Kim, MD; Kyung-Su Kim, MD, PhD OBJECTIVE: Berberine is a bitter-tasting, yellow, plant alkaloid with a long history of medicinal use in Chinese and Ayurvedic medicine. There is some evidence to support its use in the treatment of heart failure, malaria, diabetes, glaucoma, hypercholesterolemia, diarrhea, trachoma, and leishmaniasis. Traditionally, it has been used as antifungal, anti-inflammatory, anti-viral, and in respiratory disorders. However, there is no evidence that berberine can suppress the mucin secretion in the human airway. Therefore, we sought whether berberine suppresses IL-1 beta-induced MUC5AC gene expression in NCI-H292 cells and to examine which mitogen-activated protein kinases (MAPKs) were related to MUC5AC gene suppression. METHOD: After cells were pretreated with berberine and treated with IL-1 beta (10 ng/mL), MUC5AC mRNA expression was determined by RT-PCR and real-time PCR. MAPKs proteins were determined by Western blot analysis after pretreatment with berberine. RESULTS: The results showed that treatment with berberine for 24 hours suppressed MUC5AC mRNA expression in a dose-dependent manner, with significant inhibition starting from 25 microM berberine. MAPKs proteins were determined by Western blot analysis after pretreatment with 25 microM P269 Poster Presentations
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